Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …

Abstract Background Coronavirus disease 2019 (COVID‐19) can lead to systemic
coagulation activation and thrombotic complications. Objectives To investigate the incidence …

Venous thromboembolism (VTE) in patients with COVID-19 in intensive care units (ICU) is
frequent, but risk factors (RF) remain unidentified. In this meta-analysis (CRD42020188764) …

Background Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic,
the incidence of thromboembolism has been increasingly reported. The aim of this …

Introduction Venous thromboembolism (VTE) has been observed as a frequent complication
in patients with severe novel coronavirus disease 2019 (COVID-19) infection requiring …

Background: Accumulating evidence suggests that coronavirus disease 2019 (COVID-19) is
associated with hypercoagulative status, particularly for critically ill patients in the intensive …

Background The prevalence of venous thromboembolic event (VTE) and arterial
thromboembolic event (ATE) thromboembolic events in patients with COVID-19 remains …

Background Venous thromboembolism (VTE) may complicate the course of Coronavirus
Disease 2019 (COVID-19). Objectives To evaluate the incidence of VTE in patients with …